ELOX
Eloxx Pharmaceuticals, Inc.Company with tickers: ELOX
CIK
1035354
CUSIP
29014R202
Shares Outstanding
3,436,314
Website
https://www.eloxxpharma.com
Investor Relations
https://www.eloxxpharma.com/investors/
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Nina Kjellson | Director | Appointed | 2026-06-01 |
| Stephen W. Webster | Director | Appointed | 2026-06-01 |